Targeting mitochondrial metabolism for early detection and treatment of doxorubicin-induced cardiotoxicity (KT) AND Targeting bacterial DNA repair to combat antibiotic resistance (TLH)
E-mail carolyn.thackrah@pharm.ox.ac.uk for joining instructions
Abstract not yet added
Date: 27 October 2020, 13:00 (Tuesday, 3rd week, Michaelmas 2020)